Portfolio Performance Signals
Portfolios
3
At-Risk Programs
3
Forecast Variance
6.4%
Portfolios
At-Risk Programs
Forecast Variance
Home/portfolio
Portfolio
Portfolio performance and risk posture across the full development pipeline. This workspace exists to enforce consistent clinical execution with accountable ownership, governed evidence, and inspection-ready traceability across the study lifecycle. It supports business and regulatory requirements by connecting operations, quality, submissions, and financial controls in a single system where handoffs are explicit and auditable. Users can proceed by filtering scope, reviewing linked artifacts and actions, and routing escalations with defined approval gates and signature meaning.
Portfolio Decisions Queue
PORT-01 | OncologyOn Track | programs 4 | burn variance 2%
PORT-02 | ImmunologyEscalated | programs 3 | burn variance 3%
PORT-03 | Rare DiseaseEscalated | programs 3 | burn variance 4%
Add Portfolio Decisions Queue Entry
Access & Governance Controls
RBAC+ABACStudy Firewall Active
Operational Controls
Study firewalling chips highlight boundary, country constraints, and vendor partition rules.
Actions requiring GxP control include a human review checkpoint and e-signature meaning capture.
Every state change writes immutable audit evidence with actor, timestamp, and object reference.
Next Actions
Filter to portfolio/program/study context.
Open linked tasks, risks, and document evidence.
Escalate blocked items through governed workflow.